Late complications of chemotherapy in testicular cancer

被引:22
|
作者
Pliarchopoulou, Kyriaki [1 ]
Pectasides, Dimitrios [1 ]
机构
[1] Univ Athens, Dept Internal Med 2, Propaedeut Oncol Sect, Attikon Univ Hosp, Athens, Greece
关键词
Germ-cell tumors; Toxicity; Long-term survivors; GERM-CELL TUMORS; LONG-TERM SURVIVORS; CORONARY-ARTERY DISEASE; COMBINATION CHEMOTHERAPY; RENAL-FUNCTION; RAYNAUDS-PHENOMENON; SECONDARY LEUKEMIA; FOLLOW-UP; 2ND CANCERS; CARDIOVASCULAR RISK;
D O I
10.1016/j.ctrv.2009.12.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cisplatin-based treatment has significantly increased survival in testicular cancer patients. Therefore, there has been enough interest for the late toxic effects of chemotherapy which affect the quality of life of the cancer survivors. These toxic effects may either persist or present long after the end of chemotherapy and involve the impairment of renal function, neurotoxicity, pulmonary toxicity and vascular disease. Also, a major issue experienced by a large number of patients is infertility, which has been improved due to modified surgical techniques, reduced treatment intensity, the use of sperm cryopreservation and methods of assisted reproduction. Physicians should also be aware of the risk of secondary malignancy development. Therefore, close follow-up of the testicular cancer survivors as well as, focus on minimizing treatment complications through improvement of treatment strategies are warranted. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:262 / 267
页数:6
相关论文
共 50 条
  • [31] Late relapse of testicular cancer
    Martin E. Lipphardt
    Peter Albers
    World Journal of Urology, 2004, 22 : 47 - 54
  • [32] Late relapse of testicular cancer
    Lipphardt, ME
    Albers, P
    WORLD JOURNAL OF UROLOGY, 2004, 22 (01) : 47 - 54
  • [33] LATE RECURRENCE OF TESTICULAR CANCER
    EMBIL, JM
    WEINERMAN, BH
    CANADIAN JOURNAL OF SURGERY, 1994, 37 (02) : 165 - 167
  • [34] Late relapse of testicular cancer: Recurrence after 24 years and treatment with chemotherapy alone
    Akar, Emre
    Tural, Deniz
    Arslan, Deniz
    Bassorgun, Cumhur Ibrahim
    Yildiz, Ozcan
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2015, 11 (03) : 661
  • [35] Complications of open primary and post-chemotherapy retroperitoneal lymph node dissection for testicular cancer
    Subramanian, Vairavan S.
    Nguyen, Carvell T.
    Stephenson, Andrew J.
    Klein, Eric A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2010, 28 (05) : 504 - 509
  • [36] Complications during cisplatin based primary chemotherapy in patients with testicular cancer: Is there a need for thromboembolic prophylaxis
    Pfister, D.
    Wolsky, I
    Porres, D.
    Thissen, A.
    Heidenreich, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 5 - 5
  • [37] RETROPERITONEAL LYMPHADENECTOMY FOLLOWING CHEMOTHERAPY FOR TESTICULAR CANCER - ANALYSIS OF POSTOPERATIVE COMPLICATIONS ACCORDING TO ZURICH CLASSIFICATION
    Jeremic, D.
    Vojinov, S.
    Levakov, I
    Dejanovic, N.
    Marusic, G.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (06) : 576 - 576
  • [38] Management of Late Relapses After Chemotherapy in Testicular Cancer: Optimal Outcomes with Dose-intense Salvage Chemotherapy and Surgery
    Alifrangis, Constantine
    Lucas, Olivia
    Benafif, Sarah
    Ansell, Wendy
    Greenwood, Michelle
    Smith, Shievon
    Wilson, Peter
    Thomas, Ben
    Rudman, Sarah
    Mazhar, Danish
    Berney, Dan
    Shamash, Jonathan
    EUROPEAN UROLOGY FOCUS, 2021, 7 (04): : 835 - 842
  • [39] Gynecomastia following chemotherapy for testicular cancer
    Uygur, MC
    Özen, H
    UROLOGIA INTERNATIONALIS, 2003, 70 (03) : 253 - 254
  • [40] CHEMOTHERAPY IN THE TREATMENT OF TESTICULAR CANCER IN ADULTS
    LEDUC, A
    GISSELBRECHT, C
    LEDOZE, H
    MIGNOT, L
    PRESSE MEDICALE, 1985, 14 (05): : 271 - 275